Exhibit 107
Calculation of Filing Fee Table
Form S-3
(Form Type)
Renalytix plc
(Exact Name of Registrant as Specified in its Charter)
Table 1: Newly Registered Securities
| Security Type | Security Class Title | Fee Calculation Rule | Amount Registered(1)(2) | Proposed Maximum Offering Price Per Unit | Maximum Offering Price | Fee Rate | Amount of Registration Fee(3) | |||||||
| Equity | American Depositary Shares (ADSs) | 457(c) | 13,407,921 | $0.383(3) | $5,128,529.78 | $0.00014760 | $756.97 | |||||||
| Total Offering Amounts | $5,128,529.78 | — | ||||||||||||
| Net Fee Due | $756.97 | |||||||||||||
| (1) | The ordinary shares, nominal value £0.0025 per share, or the Ordinary Shares, may be represented by the American Depositary Shares, or ADSs, of Renalytix plc, or the Company. Each ADS represents two Ordinary Shares. These shares consist of up to 26,815,841 Ordinary Shares (equivalent of 13,407,921 ADSs). The total shares being registered equate to 13,407,921 ADSs. |
| (2) | Pursuant to Rule 416 under the Securities Act, the ADSs being registered hereunder include such indeterminate number of Ordinary Shares as may be issuable with respect to the ADSs being registered hereunder as a result of stock splits, stock dividends or similar transactions. |
| (3) | Estimated solely for the purpose of computing the amount of the registration fee pursuant to Rule 457(c) under the Securities Act of 1933, as amended. The calculation of the proposed maximum aggregate offering price of the ADSs is based on the average of the high and low price for the ADSs on May 30, 2024, as reported on the Nasdaq Global Market. |
